• Subscribe
  • Newsfeed
  • About
  • Jobs
AI Search
Announce News

Athernal Bio: Venture Capital Funding History

Athernal Bio

To add a bio or update company history, please click update information.

News from Athernal Bio

    Athernal Bio launches with £3.5m in funding from Delin Ventures to develop therapies for blood cancer precursor conditionsAthernal Bio launches with £3.5m in funding from Delin Ventures to develop therapies for blood cancer precursor conditions
    Athernal Bio
    2 Oct 2025

    Athernal Bio launches with £3.5m in funding from Delin Ventures to develop therapies for blood cancer precursor conditions

    Athernal Bio is developing immunotherapies for clonal haematopoiesis, aiming to stop blood cancers before they develop in high-risk patients.

Athernal Bio
  • Life Sciences
  • Cambridge, United Kingdom
  • £3.5m
  • athernalbio.com
  • Update Information

More venture news

  • Neobe lands a £5m seed round led by ARC Ventures to deliver cancer drugs directly into solid tumours
    Neobe Therapeutics
    10 Nov 2026

    Neobe lands a £5m seed round led by ARC Ventures to deliver cancer drugs directly into solid tumours

    SeedLife Sciences
  • PhaSER Biomedical secures a £2m grant from Gates Foundation to discover new treatments for neglected diseases
    PhaSER Biomedical
    9 Nov 2026

    PhaSER Biomedical secures a £2m grant from Gates Foundation to discover new treatments for neglected diseases

    GrantLife Sciences
  • Alethio Therapeutics secures a £67m Series A round led by Sofinnova Partners and RA Capital to develop targeted blood cancer therapies
    Alethio Therapeutics
    5 Nov 2026

    Alethio Therapeutics secures a £67m Series A round led by Sofinnova Partners and RA Capital to develop targeted blood cancer therapies

    Series ALife Sciences

Sign-up to our newsletter

The UK Weekly email covers every VC round from last week, firms that are hiring, and much more

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn

Announce

  • Share your story

General

  • Read the latest
  • About Soapbox

Information not up to date?

Get in touch

Soapbox Ventures Limited © 2026

Disclaimer

Privacy Policy

LinkedIn